Abstract Phosphatidate phosphatase-1 (PAP-1) converts phosphatidate to diacylglycerol and plays a key role in the biosynthesis of phospholipids and triacylglycerol (TAG). PAP-1 activity is encoded by members of the lipin family, including lipin-1 (1a and 1b), -2, and -3. We determined the effect of lipin-1 expression on the assembly and secretion of very low density lipoproteins (VLDL) using McA-RH7777 cells. Expression of lipin-1a or -1b increased the synthesis and secretion of [ 3 H]glycerol-labeled lipids under either basal-or oleate-supplemented conditions. In the presence of oleate, the increased TAG secretion was mainly associated with VLDL 1 (S f . 100) and VLDL 2 (S f 20-100). Expression of lipin-1a or -1b increased secretion efficiency and decreased intracellular degradation of [
The major lipoproteins carrying triacylglycerol (TAG) in fasted human plasma are VLDL that are synthesized by the liver. Formation of hepatic VLDL requires the active synthesis of various lipid constituents (e.g., TAG, cholesterol, cholesteryl esters, and phospholipids) that are assembled together with the large, hydrophobic apolipoprotein B100 (apoB100) (1) (2) (3) , and the assembly process is initiated during or immediately after translation and translocation of apoB100 across the endoplasmic reticulum (ER) membranes (4) . The microsomal triglyceride transfer protein (MTP), encoded by the abetalipoprotenemia gene mttp, is essential for VLDL assembly and secretion (5-7), promoting TAG partitioning into the microsomes (8) (9) (10) . The TAG utilized for the assembly process is derived from de novo glycerolipid biosynthesis and also from hydrolysis/ re-esterification of preexisting TAG (11) or phospholipids (12, 13) . A key enzyme involved in the de novo biosynthesis of TAG and phospholipids is phosphatidate phosphatase-1 (PAP-1), which converts of phosphatidate (PA) to diacylglycerol (DAG) (14, 15) . The resulting DAG serves as substrate for the synthesis of TAG as well as phosphatidylcholine (PC) and phosphatidylethanolamine (PE).
There are two classes of enzymes that convert PA to DAG in the liver, namely PAP-1 and PAP-2. The PAP-1 activity is specific toward PA and is Mg 21 -dependent, and can be inhibited by N-ethylmaleimide (15) (16) (17) (18) . The PAP-2 enzymes degrade a variety of bioactive lipid phosphates, and their activity is N-ethylmaleimide-insensitive and Mg 21 independent. In hepatic cells, PAP-1 activity is increased by glucocorticoids, an effect that is synergized by glucagon through cAMP formation and antagonized by insulin (19, 20) . Thus, increased PAP-1 activity under stress or other aberrant metabolic conditions (such as starvation, diabetes, and post-alcohol consumption) augments the capacity to sequester an increased FA supply to the liver as TAG (14) .
Mammalian PAP-1 is encoded by the lipin gene family, which consists of lipin-1, -2, and -3 (18, 21) . The Lpin1 gene gives rise to two alternative splicing isoforms, lipin1a and -1b (22) . All of these lipins possess PAP-1 activity specific toward PA (18) . In mice, lipin-1 is expressed at high levels in adipose tissue, heart, and skeletal muscle, where it is the sole PAP-1 enzyme, and at moderate levels in kidney, lung, brain, and liver (18, 21) . In mature 3T3-L1 adipocytes, the two lipin-1 splicing isoforms exhibit different subcellular localization, with lipin-1a being primarily nuclear and lipin-1b cytoplasmic (22) . This subcellular localization of lipin-1 appears to influence its function; reconstitution of lipin-1-deficient cells with lipin-1a induces adipogenic gene expression, whereas lipin-1b promotes gene expression of enzymes involved in lipid synthesis (22) .
The role of lipin-1 in adipogenic gene expression and TAG biosynthesis in adipose tissue has been documented (22) (23) (24) . Mutations in the mouse Lpin1 gene prevent normal adipose tissue development, and result in lipodystrophy (21, (25) (26) (27) . Transgenic mice expressing lipin-1 specifically in adipocytes have enhanced TAG storage and become obese (23) . Lipin-1 also promotes hepatic TAG storage and FA oxidation through transcriptional regulation of the peroxisome proliferator-activated receptor-a (PPARa) and PPAR coactivator protein-1a (PGC-1a) complex (28) . Lipin-1 deficiency in the fatty liver dystrophy ( fld) mouse strain does not preclude hepatic TAG synthesis or secretion during the neonatal period when the animals consume a high-fat diet (29) . Rather, PAP-1 activity in fld mice is normal, owing to the presence of lipin-2 and probably increased expression of lipin-3 (18) .
We have previously shown that TAG synthesis, apoB synthesis and stability, and VLDL secretion in primary rat hepatocytes were all increased by the glucocorticoid dexamethasone, whereas insulin counteracted these effects (30) (31) (32) . On the basis of recent discoveries showing that a) the expression of lipin-1, but not lipin-2 or -3, can be upregulated by glucocorticoids and suppressed by insulin in mouse and rat hepatocytes (33) , and b) the promoter region of Lpin1 contains a functional glucocorticoid response element (34), we postulated that lipin-1 is the link between glucocorticoid treatment and enhanced hepatic VLDL secretion. Upregulation of lipin-1 may provide a mechanism for converting excess FAs, derived from lipolysis in adipose tissue in starvation, diabetes, and other conditions of metabolic stress, into TAGs that are secreted as VLDL or stored as lipid droplets (14, 35) . In the present study, we tested the effect of alterations in hepatic lipin-1 expression on VLDL assembly and secretion using gainand loss-of-function approaches for lipin-1a and -1b, as well as for a mutant form of lipin-1a in which the nuclear localization signal (NLS) sequences were deleted. Results presented herein provide strong evidence that the level and compartmentalization of lipin-1 exert a major impact on VLDL assembly and secretion.
METHODS

Materials
Cell culture media and reagents, mouse anti-V5 monoclonal antibody, goat anti-mouse IgG conjugated with Alexa Fluor 488, goat anti-rabbit IgG conjugated with Alexa Fluor 599, and SlowFade Light AntiFade were purchased from Invitrogen (Burlington, ON). DNA restriction and modification enzymes were obtained from New England Biolabs (Pickering, ON). Protein A-Sepharose™ CL-4B beads, [ 35 S]methionine/cysteine (1,000 Ci/mmol), and HRP-linked anti-mouse IgG antibody were obtained from Amersham Biosciences (Baie dʼUrfe, PQ). (2- 3 H]glycerol (9.6 Ci/mmol) was obtained from Amersham (Piscataway, NJ). Protease inhibitor cocktail (EDTA-free) and chemiluminescent substrates were purchased from Roche Diagnostics (Laval, PQ). Lipid standards were obtained from Avanti Polar Lipids (Alabaster, AL). Antibodies against apoE, lamin A, b-actin, and calnexin were obtained from BioDesign (Saco, ME), Abcam (Hornby, ON), Ambion (Austin, TX), and Stressgen (Ann Arbor, MI), respectively. Polyclonal anti-lipin-1 antiserum against the synthetic polypeptide SKTDSPSRKKDKRSRHLGADG (36) and antiserum against rat VLDL were produced in our laboratory.
Mouse lipin-1 expression plasmids and transfection
The coding sequences of lipin-1a, -1b (22) , and DNLS (a variant of lipin-1a that lacked the NLS sequence KKRRKRRRK) were originally prepared in the pcDNA3.1/V5-His-TOPO expression system. The coding sequences for lipin-1a and -1b were excised by digestion with KpnI and PmeI and inserted into the pCMV5 vector that had been digested with KpnI and SmaI. The resulting pCMV5-based expression plasmids were transfected into McA-RH7777 cells by the calcium phosphate precipitation method (37) . All analyses were performed 48 h posttransfection.
Lipin-1 knockdown
Double-stranded ON-TARGETplus SMARTpool: short interfering RNAs (siRNAs) (see supplementary Table I ) specific for rat lipin-1 were obtained from Dharmacon, Inc. (Lafayette, CO). McA-RH7777 cells (50% confluence) were cultured in DMEM containing 20% FBS, and transfected with 80 pmol lipin-1 siRNA (100 nM final concentration) using different concentrations (0.025, 0.05, or 0.075 mg/ml) of Lipofectamine™ 2000 (Invitrogen), according to the manufacturerʼs instructions. The highest lipin-1 knockdown was observed at 0.075 mg/ml of Lipofectamine; this concentration was used for all subsequent metabolic labeling experiments and for gene expression analyses by real-time RT-PCR. The transfection medium was replaced with DMEM containing 20% FBS 4.5 h posttransfection. For each experiment, controls for lipin-1 knockdown were performed with functional nontargeting control siRNA (Dharmacon), which can silence firefly luciferase, or with Lipofectamine™ 2000 alone. Cells were harvested 48 h after transfection and subjected to immunoblot analysis (for lipin-1) or used for the metabolic labeling experiments described below.
Analysis of lipin-1 expression
Cell lysates of equal amounts of proteins were resolved by denaturing SDS-PAGE (8% gel), and transferred onto nitrocellulose membranes. Recombinant lipin-1 variants were detected using mouse anti-V5 antibody. In parallel experiments, cells were labeled with [ 35 S]methionine/cysteine (75 mCi/dish) for 4 h in media containing 20% FBS and 0.4 mM oleate. Cell-associated lipin-1 was recovered by immunoprecipitation using polyclonal anti-lipin-1 antiserum, and subjected to denaturing SDS-PAGE (8% gel) and autoradiography.
PAP-1 assay
The PAP-1-specific activity in lipin-1-transfected McA-RH7777 cells and primary rat hepatocytes was determined according to protocols described previously (33) .
Immunofluorescence microscopy
Cells cultured on fibronectin-coated coverslips were incubated in DMEM 6 0.4 mM oleate for 2 h at 37°C. Cells were then fixed with 4% paraformaldehyde for 30 min, and then permeabilized with 0.1% Triton X-100 in PBS for 5 min at room temperature. The cells were blocked with 10% FBS (in PBS) for 1 h, rinsed, and incubated with mouse anti-V5 monoclonal antibody (5 mg/ml) plus rabbit anti-lamin A polyclonal antibody (0.1 mg/ml) for 1 h. After rinsing with PBS, cells were stained with goat anti-mouse IgG conjugated with Alexa Fluor 488 and goat anti-rabbit IgG conjugated with Alexa Fluor 599. The coverslips were mounted onto glass slides using SlowFade Light AntiFade. Confocal images were captured using a 1003 NA1.4 oil objective on an Olympus IX81 inverted microscope with appropriate lasers (488 nm argon/krypton laser for Alexa 488, and the 543 nm green helium-neon laser for Alexa 599).
Subcellular fractionation
Subcellular fractionation was performed as described previously (9) . Briefly, lipin-1 expressing cells (8-10 100 mm dishes) were homogenized by passing 20 times through a ball-bearing homogenizer. Cell homogenates were centrifuged (12,000 g, 10 min, 4°C) to obtain nuclear membranes (pellet) and the postnuclear supernatant, which was transferred to a quick-seal centrifuge tube and centrifuged using a Beckman TLA-100.4 rotor (174,000 g, 30 min, 4°C) to obtain cytosol (supernatant) and microsomes (pellet). Aliquots of the fractionated samples were subjected to denaturing SDS-PAGE and immunoblot analysis for lipin-1. Antibodies against lamin, calnexin, and actin were used to probe for nucleus, microsomes, and cytosol, respectively.
Metabolic labeling of lipids
Cells were labeled with [ 3 H]glycerol (4 mCi/ml, 2 ml/dish) in DMEM containing 20% FBS 6 oleate (0 to 0.4 mM) for 1, 2, or 4 h. Total lipids were extracted from cells and media, respectively, and separated by TLC as described previously (38) . The radioactivity associated with [ 3 H]TAG, -PC, -PE and -DAG was quantified by scintillation counting.
Metabolic labeling of proteins
Cells were labeled with [
35 S]methionine/cysteine (75 mCi/ml) for 4 h in methionine/cysteine-free DMEM containing 20% FBS 6 0.4 mM oleate. At the end of labeling, the media and cells were collected, and the 35 S-labeled apoB100, apoE, and lipin-1 were respectively recovered by immunoprecipitation. Proteins were resolved by denaturing SDS-PAGE (5, 8, and 12% gels for apoB100, lipin-1, and apoE, respectively). Radioactivity associated with these proteins was quantified by scintillation counting (9 Pulse-chase analysis of apoB100 and apoE Cells were pulse-labeled with [ 35 S]methionine/cysteine (75 mCi/ml) for 30 min. The media were removed and replaced with chase media (DMEM containing 20% FBS and 0.4 mM oleate) for up to 4 h. At the end of chase, [
35 S]apoB100 and -apoE were recovered from media and cells, respectively, by immunoprecipitation, and subjected to denaturing SDS-PAGE and scintillation counting as described previously (9) .
MTP activity assay
Lipin-1 expressing cells were suspended in hypotonic buffer (1 mM Tris-HCl, pH 7.4, 1 mM MgCl 2 , and 1 mM EGTA) containing protease cocktail inhibitors, and homogenized using a Polytron homogenizer. After centrifugation using a Beckman microcentrifuge at 10,000 rpm, 4°C for 30 min, the supernatants were used for MTP activity assay (with 25 mg protein per assay) as described previously (39, 40) .
Quantification of RNA by real-time RT-PCR
Isolation of RNA from cells, reverse transcription, and relative mRNA concentration determination by real-time RT-PCR were performed according to previously described protocols using cyclophilin A as control (33) . The RT-PCR primer sequences for genes of interest are listed in supplementary Table II .
Statistical analysis
Values are expressed as means 6 SE. The significance of differences among control and lipin-1-expressing cells was analyzed using Studentʼs t-test, two-sample equal variance. P , 0.05 was considered significant.
Other assays
Protein concentrations in the cells were quantified by the Bradford method (41).
RESULTS
Lipin-1 expression level governs glycerolipid synthesis and secretion
Transfection of lipin-1a or -1b plasmids into McA-RH7777 cells resulted in expression of the respective lipin-1 isoforms, which were readily detectable in cell lysate with the anti-V5 antibody (Fig. 1A, left panel) . Metabolic labeling followed by immunoprecipitation using anti-lipin-1 antibody also detected the recombinant protein (Fig. 1A, right panel) . Determination of PAP-1 activity using cell lysates showed increased PAP-1 activity following lipin-1 expression (Fig. 1B) . Confocal microscopy of dual immunofluorescent staining of lamin (nuclear membrane marker) and lipin-1 confirmed that lipin-1a was present predominantly in the nucleus (Fig. 1C, panel a) , and lipin-1b in the cytoplasm (panel b). The transfection efficiency of lipin-1 plasmids in these cells was #20% as determined by immunofluorescent microscopy.
The respective contribution of lipin-1a and -1b to glycerolipid synthesis and secretion was determined by metabolic labeling experiments under lipid-poor (i.e., no serum, no oleate) or lipid-rich (i.e., supplemented with serum and/or oleate) conditions. Fig. 2A) . Supplementation of oleate into the serum-free media stimulated the incorporation of [ 3 H]glycerol into cell-associated TAG (Fig. 2B) .(Note different scales of y axis for left panel in Fig. 2A, B. ) Under oleate supplement conditions, the rate of [ 3 H]TAG secretion from lipin-1a and -1b cells was markedly increased as compared with vector-transfected controls (Fig. 2B, panel b) . Likewise, incorporation of [ 3 H] glycerol into secreted PC, PE, and DAG was also increased from lipin-1a and -1b cells (Fig. 2B, panel b) . When metabolic labeling experiments were performed in the presence of serum, an increase in cell-associated and medium [ 3 H] lipids was also observed in lipin-1-expressing cells (Fig. 2C) , and oleate supplementation further increased their rate of synthesis and secretion (Fig. 2D) (Fig. 2B, D) .
The requirement of lipin-1 for glycerolipid synthesis and secretion was further determined using a loss-of-function approach. Transfection of McA-RH7777 cells with lipin-1-specific siRNA resulted in ?55% decrease in lipin-1 protein (Fig. 3A) and similar decrease in the relative mRNA concentration of lipin-1 (with respect to cyclophilin A) (Fig. 3B) . The relative mRNA concentrations of lipin-2 or -3 were not changed significantly by the lipin-1 siRNA treatment (Fig. 3B) . The primer efficiencies for lipin-1, -2, and -3 were 1.99, 1.90, and 2.0, respectively, during real-time RT-PCR reactions, and the corresponding cycles required to detect lipin-1, -2, and -3 were 26, 22, and 24. The higher number of threshold cycles required for lipin-1 indicated that lipin-1 may be the least-abundant lipin in McA-RH7777 cells. The lipin-2 or -3 protein levels were not determined, owing to the lack of suitable specific antibodies. The PAP-1 assay showed that lipin-1 siRNA treatment did not decrease the overall PAP-1 activity in the cells (Fig. 3C) . This confirms that lipin-1 expression in untreated cells is low compared with that of lipin-2 and -3.
Following lipin-1 knockdown, secretion of [ 3 H]glycerollabeled TAG, PC, PE, and DAG was reduced by .2-fold as determined by metabolic labeling experiments (Fig. 3D,  panel a) between control and lipin-1 siRNA-treated cells (Fig. 3D,  panel b) . This result is compatible with the lack of an effect of lipin-1 knockdown on total PAP-1 activity, which is contributed mainly by lipin-2 and -3. The observed effect of the knockdown on [
3 H]glycerolipid secretion points to a specific role of lipin-1 in this process.
The medium lipoproteins secreted from cells cultured under lipid-rich conditions (i.e., 1 serum and 1 oleate) (Fig. 4B) . The secretion of [ 3 H]PE in association with lipoproteins was not affected significantly by lipin expression (Fig. 4C) , whereas secretion of [ 3 H]DAG in VLDLs was increased, although it did not reach statistical significance (Fig. 4D) . These results provide the first indication that de novo synthesis of glycerolipids and their secretion as VLDLs are increased by expression of lipin-1 (regardless of isoform), presumably as a consequence of increased production of DAG in these cells.
Lipin-1 expression level correlates positively with apoB100 synthesis and secretion
Transient expression of lipin-1a or -1b resulted in increased (by 2-fold) incorporation of [ 35 S]methionine into cell-associated (Fig. 5A, panel a) and secreted apoB100 (panel b), as compared with controls (i.e., transfected with vector alone). The effect of lipin-1a and -1b was specific to apoB100, because incorporation of [ 35 S]methionine into apoE was unaffected (Fig. 5A, bottom panels) . A similar stimulatory effect of lipin-1 expression on [ 35 S]apoB100 secretion was observed when cells were labeled in the absence of oleate (results not shown). Fractionation of medium lipoproteins showed that the increased secretion of [ 35 S]apoB100 from lipin-1a or -1b expressing cells was mainly associated with VLDL 1 and VLDL 2 (Fig. 5B, C) Knockdown of endogenous lipin-1 using siRNA resulted in decreased [ 35 S]apoB100 in the cells (Fig. 6A , panel a) and media (panel b) by .2-fold, as compared with controls. Neither the synthesis nor the secretion of apoE was affected following lipin-1 knockdown (Fig. 6A) . These results demonstrate that the level of lipin-1 expression in McA-RH7777 cells exerts a strong influence on the synthesis and secretion of apoB100. The relative mRNA concentrations for PGC-1a or PPARa were marginally or unaffected by lipin-1 knockdown (Fig. 6B) .
To gain further insight into mechanisms by which the level of lipin-1 expression affects [ 35 S]methionine incorporation into apoB100, we performed pulse (30 min) -chase (up to 4 h) experiments to determine the posttranslational stability and secretion efficiency of newly synthesized apoB100. At the end of 30 min pulse labeling, the incorporation of [ 35 S]methionine into apoB100 in lipin-1a or -1b cells was similar to or slightly higher than that in control cells (Fig. 7A, open bars in panel a) . The same trend was observed when pulse labeling was performed in the presence of the proteasome inhibitor MG132 to block cotranslational apoB100 degradation (Fig. 7A,  closed bars in panel a) . At the end of the initial 30 min chase, the incorporation of [ 35 S]methionine into apoB100 in lipin-1a and lipin-1b cells was noticeably higher than that in control cells (Fig. 7A, panel b) . These results are in agreement with our metabolic labeling studies showing increased apoB100 accumulation in the cells upon lipin-1 expression (Fig. 5A) . We next determined the secretion efficiency of apoB100 at 30 min and up to 4 h chase. Secretion efficiency was defined as the percent of newly synthesized apoB100 proteins secreted during chase. Representative fluorograms of [ 35 S]apoB100 in cells and media during chase are shown in the top panels of Fig. 7B, C . Quantification of radioactivity associated with [ 35 S]apoB100 showed that the secretion efficiency of apoB100 (particularly between 1 and 2 h chase) was increased from lipin-1a and -1b expressing cells as compared with vector-transfected controls (Fig. 7B, bottom panel) . Similarly to what was observed for [ 3 H]TAG secretion (Fig. 2D) , lipin-1b exerted a greater effect than lipin-1a on apoB100 secretion efficiency, as demonstrated throughout the entire chase period (Fig. 7B, bottom panel) . The cell-associated apoB100 during chase was not affected by lipin-1a or -1b expression (Fig. 7B, middle panel) . The kinetics of cell-associated apoE was not affected by lipin-1a or -1b expression, nor was apoE secretion efficiency (data not shown). In experiments where MG132 was included in the pulse-labeling media, the stimulatory effect of lipin-1b on apoB100 secretion was diminished (Fig. 7C, bottom panel) . Under these conditions (i.e., blockage of proteasome function during pulse labeling), secretion of apoB100 from vectortransfected control cells was nearly as efficient as that from lipin-1b cells. These results suggest that the increased apoB100 secretion efficiency observed in lipin-1b cells was at least partly attributable to attenuated cotranslational degradation of newly synthesized apoB100. The MG132 treatment had little effect on apoB100 secretion from (Fig. 7C, bottom  panel) . The MG132 treatment had little effect on cellassociated apoB100 (Fig. 7C, middle panel) or apoE (results not shown). Determination of lipid transfer activity of MTP using cell lysates showed that transient expression of lipin-1a or -1b in McA-RH7777 cells had little effect on MTP (results not shown). These results indicate that expression of lipin-1, especially lipin-1b, confers a stimulatory effect on apoB100 secretion efficiency, presumably through decreasing cotranslational degradation of newly synthesized apoB100.
Deletion of the NLS in lipin-1a reduces the synthesis and secretion of [ 3 H]TAG and [ 35 S]apoB100
Because lipin-1a and -1b differ in their subcellular localization, we considered the possibility that their different effects on apoB100 secretion efficiency (Fig. 7B, C) might be attributable to compartmentalization of lipin-1 isoforms. Thus, we contrasted the function of wild-type lipin-1a in hepatic glycerolipid synthesis with that of a variant that lacked the NLS sequence (DNLS). Transfection of the DNLS plasmid into McA-RH7777 cells resulted in normal expression of the protein (Fig. 8A) . As expected, the DNLS protein lost its nuclear localization, and appeared predominantly in the cytoplasm (Fig. 8B) . Subcellular fractionation experiments confirmed the lack of nuclear localization of the DNLS mutant (Fig. 8C, panel a) . However, unlike wildtype lipin-1a or -1b, the DNLS mutant lost the ability to associate with microsomal membranes (Fig. 8C, panel b) and became mainly cytosolic (panel c). These results suggest that the NLS sequences not only govern nuclear localization but also determine membrane association and physiological function of lipin-1a.
The expression of DNLS increased PAP-1 activity to nearly the same extent as the wild-type lipin-1a (Fig. 9A) . Metabolic labeling experiments showed that cell-associated [ 3 H]TAG and -PC were lower in DNLS expressing cells as compared with those expressing the wild-type lipin-1a (Fig. 9B, panel a) . Likewise, secretion of [ 3 H]TAG and -PC was also decreased from DNLS expressing cells as compared with wild-type lipin-1a (Fig. 9B, panel b) (Fig. 9C, panel a) or secreted (panel b) apoB100. Synthesis or secretion of apoE was not affected by lipin-1a or DNLS expression (Fig. 9C) . These results indicate that the subcellular localization of lipin-1a indeed has an impact on hepatic lipogenesis and apoB100 synthesis/secretion.
DISCUSSION
Lipin-1 expression is a specific target for differential regulation by glucocorticoids and insulin in the liver, and this has important physiological significance. In primary rat and mouse hepatocytes, dexamethasone treatment stimulates the expression of lipin-1, but not lipin-2 or -3, through a glucocorticoid response element within the Lpin1 promoter (33, 34) . Our present transfection studies with McA-RH7777 cells suggest that although lipin-1, -2, and -3 all encode PAP-1 activity in these cells (Fig. 3) , it is lipin-1 that is responsible for the previously observed increase in VLDL secretion upon glucocorticoid treatment (30) (31) (32) . The observed close relationship between lipin-1 expression (gain-and loss-of-function) and apoB100 synthesis and secretion (Figs. 5A, 6A ) underscores the importance of lipid substrate availability in promoting VLDL assembly and decreasing cotranslational degradation of apoB. In accordance with this, overexpression of acylCoA:diacylglycerol acyltransferase (DGAT 1 ), the enzyme that catalyzes the final step in the de novo TAG biosyn- thesis pathway, also results in increased hepatic TAG concentrations and VLDL secretion (42, 43) . Because lipin-2 and -3 are present in McA-RH7777 cells, simply knocking down lipin-1 did not result in a noticeable decrease in PAP-1 activity (Fig. 3C ). This suggests that the three lipin proteins can compensate each other in the total expression of PAP-1 activity (18) . However, it is specifically lipin-1 that is responsible for the glucocorticoid-induced increase in PAP-1 activity (33) . Despite the lack of changes in total PAP-1 activity following lipin-1 knockdown, [ 3 H]TAG secretion was reduced significantly (Fig. 3D) . Therefore, the present work demonstrates that alterations in lipin-1 expression produce parallel changes in VLDL assembly and secretion.
Several lines of evidence reported herein point out that the increased VLDL-apoB100 and VLDL-TAG secretion following lipin-1 expression is not merely a result of a general increase in the lipid availability. Rather, association of lipin-1 with the ER is of particular importance in determining its function in VLDL assembly and secretion. Subcellular fractionation experiments revealed that although lipin-1a and -1b phenotypically exhibited nuclear and cytoplasmic localization, both proteins showed extensive association with the microsomal membranes (Fig. 8C) . Close examination of lipin-1a compartmentalization by using the DNLS mutant form of lipin-1a revealed that NLS deletion resulted in not only loss of nuclear localization but also loss of microsomal membrane association (Fig. 8C) . Moreover, expression of the lipin-1a DNLS mutant failed to stimulate [ 35 S]apoB100 or [ 3 H]TAG secretion, even though the mutant retained normal PAP-1 activity (Fig. 9) .
Thus, a close association of lipin-1, either -1a or -1b, with the ER conceivably governs the lipid substrate availability for VLDL assembly. It has been reported previously that the association of lipin-1 with microsomal membranes can be reduced by insulin treatment (44) . Insulin is known to antagonize hepatic VLDL assembly and secretion (31) . On the other hand, increased association of lipin-1 with the ER membranes was observed in cells treated with oleate (44) , which explains the early observations that translocation of PAP-1 activity from the cytosol to microsomes was promoted by exogenous oleate (45, 46) . Altogether, these results suggest strongly that association of lipin-1/PAP-1 with the ER has a major impact on hepatic VLDL assembly and secretion.
The functional significance of lipin-1a association with the nucleus is not immediately clear. It has been reported that the yeast homolog of the mammalian lipin-1, Pah1p/ Smp2p (21) , is a nuclear protein and a key regulator of phospholipid biosynthetic gene transcription and nuclear/ ER membrane growth (47) . The cellular functions of Pah1p/Smp2p are dependent upon its PAP-1 activity, which is required for normal nuclear/ER membrane structure (48) . Lipin-1 in yeast and mammalian cells has also been shown to associate with chromatin and transcription factors of several genes (28, 47) . For instance, mouse lipin-1 interacts directly with PPARa and PGC-1a, and promotes transcriptional regulation of enzymes involved in b-oxidation (28), thus raising the possibility that lipin-1 may serve a dual function in glycerolipid synthesis and transcription regulation. The present studies showed that transient expression of lipin-1 had little effect on the expression of PGC-1a or PPARa in McA-RH7777 cells (Fig. 6B) . Thus, the effect of changing lipin-1 expression on VLDL assembly and secretion in the current cell model system is achieved primarily by regulating hepatic lipogenesis.
Understanding the role that lipin-1 plays in VLDL assembly and secretion has important implications in understanding the mechanisms by which hormonal regulation impacts VLDL production under conditions of starvation, insulin resistance, diabetes, stress, and alcohol intoxication. Under such conditions, increased glucocorticoid production stimulates hepatic PAP-1 (lipin-1) activity and VLDL secretion (30) (31) (32) , whereas these effects are suppressed by insulin (20, 31, 49) . The present work provides evidence that the opposing effects of dexamethasone and insulin on VLDL secretion are mediated through the modulation of lipin-1 expression and its subcellular compartmentalization. This information is important in understanding how the liver maintains the capacity to secrete VLDL in starvation and diabetes, and why hypertriglyceridemia normally accompanies insulin resistance.
